Aarti Pharma Labs P/E Ratio
Aarti Pharma Labs P/E ratio. Aarti Pharma Labs (AARTIPHARM) P/E ratio is 38.88 (High), EPS (TTM) ₹19.27, current price ₹946.60 on NSE vs historical average P/E of 20.49 (100.0th percentile) — Very High - High growth expectations or significantly overvalued. Examine AARTIPHARM Q4 results for recent quarterly revenue, profit and EPS trends.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
AARTIPHARM P/E Ratio — Valuation Signal & Historical Context
Aarti Pharma Labs P/E 38.88 vs historical average 20.49, range 13.43–29.66 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see Aarti Pharma Labs share price screener.
- Stock appears overvalued with PE of 38.88, suggesting caution for new investments
- Current PE is 89.8% above historical average
- Trading at discount to sector average PE of 56.4
Aarti Pharma Labs P/E Ratio Historical Trend
AARTIPHARM annual price-to-earnings ratio — 3 years, EPS and year-end price. Current P/E 38.88 vs historical average 20.49. Also explore AARTIPHARM stock price history to track price trends across different timeframes.
AARTIPHARM Historical P/E Ratio — EPS, Year-End Price & Valuation
Aarti Pharma Labs annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2025 | 29.66 | 23.58 | ₹699.35 | NSE | High |
| 2024 | 18.37 | 27.51 | ₹505.35 | NSE | Moderate |
| 2023 | 13.43 | 21.47 | ₹288.25 | NSE | Low |
AARTIPHARM vs Healthcare Peers — P/E Ratio Comparison
Aarti Pharma Labs P/E 38.88 vs Healthcare average 56.4, median 31.61 — range 2.04–740.29.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 2.04 | ₹65 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.41 | ₹63 | Low |
| Sun Pharma Advanced Rese… | SPARC | 3.98 | ₹6,206 | Low |
| Dipna Pharmachem | DPL | 4.57 | ₹12 | Low |
| JFL Life Sciences | JFLLIFE | 4.88 | ₹66 | Low |
| Kabra Drugs | KABRADG | 6.09 | ₹44 | Low |
| GKB Ophthalmics | GKB | 6.27 | ₹33 | Low |
| Royal Sense | ROYAL | 6.58 | ₹47 | Low |
| Colinz Laboratories | COLINZ | 6.62 | ₹18 | Low |